Scientific Program

src=http://www.doctaforum.net/congresos/gestor/ckfinder/userfiles/images/icons/icon-pdf.png

Download program in pdf

08:30 Welcome
Cristiana Sessa
ESMO Representative
  Manuel Llombart
Regional Minister for Health, Valencia, Spain
08:45 - 09:25 Keynote Lecture: Genomic Analysis
Michael J. Birrer · Massachusetts General Hospital, Boston (MA), USA
 
SESSION - 1 - PATHOGENESIS: FROM MORPHOLOGY TO MOLECULAR DIAGNOSIS
Chairs: Michael J. Birrer · Massachusetts General Hospital, Boston (MA), USA
Ignacio Romero · Fundación Instituto Valenciano de Oncología, Valencia, Spain
09:25 - 09:50 Molecular Pathogenesis
Robert  J. Kurman · The Johns Hopkins Hospital, Baltimore (MD), USA
09:50 - 10:15 Clinical Implications
Elise C. Kohn · National Cancer Institute, Bethesda (MD), USA
10:15 - 10:25 Discussion
 
SESSION - 2 - SURGERY IN OVARIAN CANCER
Chairs: Nicoletta Colombo · European Institute of Oncology, Milan, Italy
Sergi Martínez · Hospital Clínic Universitari, Barcelona, Spain
10:25 - 10:50 State of the Art of Surgery in Advanced Ovarian Cancer
Neville F. Hacker · Royal Hospital for Women, Randwick, Australia
10:50 - 11:30 Surgical Intervention in Relapsed Ovarian Cancer is Beneficial
10:50 - 11:05 In Favor
Philipp Harter · Kliniken Essen-Mitte, Essen, Germany
11:05 - 11:20 Contra
Maurie Markman · Cancer Treatment Centers of America, Eastern Regional Medical Center, Philadelphia (PA), USA
11:20 - 11:30 Discussion
11:30 - 12:00 Coffee Break
 
SESSION - 3 - SYSTEMIC THERAPY IN OVARIAN CANCER: 1st LINE
Chairs: Jan B. Vermorken · Antwerp University Hospital, Edegem, Belgium
Antonio Casado · Hospital Clínico San Carlos, Madrid, Spain
12:00 - 12:25 Do We Have a New Standard in Suboptimal Debulked Disease?
Michael A. Bookman · Arizona Cancer Center, Tucson (AZ), USA
12:25 - 12:50 Current Situation and New Developments in IP Chemotherapy
Joan L. Walker · University of Oklahoma Health Sciences Center, Oklahoma (OK), USA
12:50 - 13:15 Update on Non-Serous Ovarian Cancer Trials
Keiichi Fujiwara · Saitama Medical University, Saitama, Japan
13:15 - 13:30 Discussion
13:30 - 15:00 Lunch
 
SESSION - 4 - SYSTEMIC THERAPY IN OVARIAN CANCER: RECURRENT
Chairs: Sandro Pignata · National Cancer Institute, Pascale, Naples, Italy
José Mª Del Campo · Hospital General Vall d'Hebron, Barcelona, Spain
15:00 - 15:25 Update on Randomized Trials on Recurrent Disease
Antonio González · MD Anderson Cancer Center, Madrid, Spain
15:25 - 16:30 Bevacizumab Should Preferably Be Used in Recurrent Disease
15:25 - 15:45 In Favor
Eric Pujade-Lauraine · Hôpital Hôtel-Dieu, Paris, France
15:45 - 16:05 Contra
Bradley J. Monk · St Joseph's Hospital and Medical Center
, Phoenix (AZ), USA
16:05 - 16:30 Discussion
16:30 - 17:00 Coffee Break
 
SESSION - 5 - NEW DEVELOPMENTS
Chairs: Elizabeth Eisenhauer · Queen's University, Kingston (ON), Canada
Andrés Cervantes · Hospital Clínico Universitario, Valencia, Spain
17:00 - 17:25 Targeted Therapies and Clinical Trials
Janet Dancey · Queen's University, Kingston (ON), Canada
17:25 - 17:50 Patient Reported Outcome in Clinical Trials
Michael Friedlander · Prince of Wales Hospital, Randwick, Australia
17:50 - 18:15 New Outlook for the Future
Stanley B. Kaye · The Royal Marsden Hospital, London, United Kingdom
18:15 - 18:30 Remarks and Conclusions
Andrés Poveda · Fundación Instituto Valenciano de Oncología, Valencia, Spain